Hester Biosciences Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹1730
- Today's High:
- ₹1759.4
- Open Price:
- ₹1757.85
- 52W Low:
- ₹1415.95
- 52W High:
- ₹2280.4
- Prev. Close:
- ₹1752.85
- Volume:
- 133
Company Statistics
- Market Cap.:
- ₹14.74 billion
- Book Value:
- 245.232
- Revenue TTM:
- ₹1.92 billion
- Operating Margin TTM:
- 23.99%
- Gross Profit TTM:
- ₹1.68 billion
- Profit Margin:
- 13.9%
- Return on Assets TTM:
- 7.35%
- Return on Equity TTM:
- 14.14%
Company Profile
Hester Biosciences Limited had its IPO on under the ticker symbol 524669.
The company operates in the Other sector and Other industry. Hester Biosciences Limited has a staff strength of 0 employees.
Stock update
Shares of Hester Biosciences Limited opened at ₹1757.85 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹1730 - ₹1759.4, and closed at ₹1730.85.
This is a -1.26% slip from the previous day's closing price.
A total volume of 133 shares were traded at the close of the day’s session.
In the last one week, shares of Hester Biosciences Limited have increased by +0.1%.
Hester Biosciences Limited's Key Ratios
Hester Biosciences Limited has a market cap of ₹14.74 billion, indicating a price to book ratio of 7.2797 and a price to sales ratio of 8.091.
In the last 12-months Hester Biosciences Limited’s revenue was ₹1.92 billion with a gross profit of ₹1.68 billion and an EBITDA of ₹591.45 million. The EBITDA ratio measures Hester Biosciences Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Hester Biosciences Limited’s operating margin was 23.99% while its return on assets stood at 7.35% with a return of equity of 14.14%.
In Q3, Hester Biosciences Limited’s quarterly earnings growth was a positive 7.7% while revenue growth was a positive 19.5%.
Hester Biosciences Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 56.9337
- PEG
Its diluted EPS in the last 12-months stands at ₹31.127 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Hester Biosciences Limited’s profitability.
Hester Biosciences Limited stock is trading at a EV to sales ratio of 8.5772 and a EV to EBITDA ratio of 26.9549. Its price to sales ratio in the trailing 12-months stood at 8.091.
Hester Biosciences Limited stock pays annual dividends of ₹6.6 per share, indicating a yield of 0.37% and a payout ratio of 21.06%.
Balance sheet and cash flow metrics
- Total Assets
- ₹6.70 billion
- Total Liabilities
- ₹1.49 billion
- Operating Cash Flow
- ₹-769990000.00
- Capital Expenditure
- ₹777.62 million
- Dividend Payout Ratio
- 21.06%
Hester Biosciences Limited ended 2024 with ₹6.70 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹6.70 billion while shareholder equity stood at ₹2.80 billion.
Hester Biosciences Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹1.49 billion in other current liabilities, 85070000.00 in common stock, ₹2.71 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹318.53 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹1.85 billion.
Hester Biosciences Limited’s total current assets stands at ₹2.28 billion while long-term investments were ₹0 and short-term investments were ₹186.97 million. Its net receivables were ₹796.31 million compared to accounts payable of ₹0 and inventory worth ₹848.10 million.
In 2024, Hester Biosciences Limited's operating cash flow was ₹-769990000.00 while its capital expenditure stood at ₹777.62 million.
Comparatively, Hester Biosciences Limited paid ₹0.21 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹1730.85
- 52-Week High
- ₹2280.4
- 52-Week Low
- ₹1415.95
- Analyst Target Price
- ₹
Hester Biosciences Limited stock is currently trading at ₹1730.85 per share. It touched a 52-week high of ₹2280.4 and a 52-week low of ₹2280.4. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹1724.79 and 200-day moving average was ₹1749.08 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 7349.6% of the company’s stock are held by insiders while 38.3% are held by institutions.
Frequently Asked Questions About Hester Biosciences Limited
Similar Industry Stocks (Other)
Most Active
Top Gainers
Top Losers
About
Hester Biosciences Limited manufactures and trades in veterinary vaccines and health products in India. It operates through Poultry healthcare, Animal Healthcare, and Others segments. The Poultry Healthcare segment vaccines for diseases such as fowl pox, Newcastle disease, infectious bronchitis, and others; feed supplements, such as growth tonic, toxin binder, and herbal supplement; disinfectants for farms and equipment; and sanitizers. The Animal Healthcare segment vaccines for large animals against Goat Pox, Peste des Petits Ruminants, and Brucellosis disease; anti-infective, antiparasite, non-steroidal anti-inflammatory, and anthelmintic drugs; food supplements, including growth tonic, mineral mixture, fertility supplement, and bypass fat; farms and equipment disinfectants; and udder management services. It also offers ELISA & PCR diagnostic kits; NDV and IBV ELISA kits for sero-monitoring of poultry; and PCR molecular diagnostic kits for various diseases. The company also exports its products. Hester Biosciences Limited has a collaboration agreement with Indian Institute of Technology Guwahati to develop vaccine against COVID-19. The company was founded in 1987 and is headquartered in Ahmedabad, India.